Literature DB >> 21741974

RNA interference-produced autoregulation of inducible nitric oxide synthase expression.

Chenzhuo Feng1, Lin Cao, Zhiyi Zuo.   

Abstract

Vector-mediated delivery of short-hairpin RNA (shRNA) to regulate gene expression holds a great therapeutic promise. We hypothesize that gene expression can be autoregulated with RNA interference. We used inducible nitric oxide synthase (iNOS) as a gene model to test this hypothesis. Lipopolysaccharide dose-dependently increased iNOS in rat aortic smooth muscle cells and the nitrite production from these cells. These increases were attenuated in cells transfected with plasmids containing code for iNOS shRNA whose expression was controlled by an iNOS promoter. The production of shRNA was lipopolysaccharide dose-dependent. The lipopolysaccharide-induced iNOS expression in rat C6 glioma cells also was attenuated by transfection with plasmids containing the iNOS shRNA code. These results provide proof-of-concept evidence for using RNA interference technique to achieve autoregulation of gene expression.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741974      PMCID: PMC3148287          DOI: 10.1016/j.febslet.2011.06.032

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  30 in total

Review 1.  RNA interference: biology, mechanism, and applications.

Authors:  Neema Agrawal; P V N Dasaradhi; Asif Mohmmed; Pawan Malhotra; Raj K Bhatnagar; Sunil K Mukherjee
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

2.  Neuroprotection by aminoguanidine after lateral fluid-percussive brain injury in rats: a combined magnetic resonance imaging, histopathologic and functional study.

Authors:  Jia Lu; Shabbir Moochhala; Md Shirhan; Kian Chye Ng; Ai Ling Teo; Mui Hong Tan; Xiao Lei Moore; Meng Cheong Wong; Eng Ang Ling
Journal:  Neuropharmacology       Date:  2003-02       Impact factor: 5.250

Review 3.  Nitric oxide and the immune response.

Authors:  C Bogdan
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

4.  Temporal and segmental distribution of constitutive and inducible nitric oxide synthases after traumatic spinal cord injury: effect of aminoguanidine treatment.

Authors:  Katina Chatzipanteli; Ronaldo Garcia; Alexander E Marcillo; Kim E Loor; Susan Kraydieh; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2002-05       Impact factor: 5.269

5.  Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic.

Authors:  Jeffery C Giering; Dirk Grimm; Theresa A Storm; Mark A Kay
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

Review 6.  Role of nitric oxide after brain ischaemia.

Authors:  M A Moro; A Cárdenas; O Hurtado; J C Leza; I Lizasoain
Journal:  Cell Calcium       Date:  2004 Sep-Oct       Impact factor: 6.817

Review 7.  Mammalian RNAi for the masses.

Authors:  Yang Shi
Journal:  Trends Genet       Date:  2003-01       Impact factor: 11.639

8.  Effects of aminoguanidine on cerebral ischemia in mice: comparison between mice with and without inducible nitric oxide synthase gene.

Authors:  Koreaki Sugimoto; Costantino Iadecola
Journal:  Neurosci Lett       Date:  2002-10-04       Impact factor: 3.046

9.  Induced nitric oxide promotes intestinal inflammation following hemorrhagic shock.

Authors:  Christian Hierholzer; Jörg C Kalff; Timothy R Billiar; Anthony J Bauer; David J Tweardy; Brian G Harbrecht
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-02       Impact factor: 4.052

10.  Aminoguanidine protects against intracranial hypertension and cerebral ischemic injury in experimental heatstroke.

Authors:  Ching-Ping Chang; Chin-Cheng Lee; Sheng-Hsien Chen; Mao-Tsun Lin
Journal:  J Pharmacol Sci       Date:  2004-05       Impact factor: 3.337

View more
  5 in total

1.  Contribution of microRNA-203 to the isoflurane preconditioning-induced neuroprotection.

Authors:  Lin Cao; Chenzhuo Feng; Liaoliao Li; Zhiyi Zuo
Journal:  Brain Res Bull       Date:  2012-05-17       Impact factor: 4.077

2.  Quantitative measurement of iNOS expression in melanoma, nasopharyngeal, colorectal, and breast tumors of Tunisian patients: comparative study and clinical significance.

Authors:  Emna Dabbeche-Bouricha; Nadia Hadiji-Abbes; Rania Abdelmaksoud-Damak; Nesrine Alaya; Wajdi Ayadi; Slim Charfi; Abdelmajid Khabir; Tahia Sellami-Boudawara; Raja Mokdad-Gargouri
Journal:  Tumour Biol       Date:  2015-11-07

3.  Regulatory factor X1-induced down-regulation of transforming growth factor β2 transcription in human neuroblastoma cells.

Authors:  Chenzhuo Feng; Zhiyi Zuo
Journal:  J Biol Chem       Date:  2012-05-11       Impact factor: 5.157

4.  Autoregulation of inducible nitric oxide synthase expression by RNA interference provides neuroprotection in neonatal rats.

Authors:  Zhi Wang; Chenzhuo Feng; Huijuan Zhao; Xiaoyan Ren; Shuling Peng; Zhiyi Zuo
Journal:  Theranostics       Date:  2015-02-15       Impact factor: 11.556

5.  Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, attenuates postoperative cognitive dysfunction in aging mice.

Authors:  Min Jia; Wen-Xue Liu; He-Liang Sun; Yan-Qing Chang; Jiao-Jiao Yang; Mu-Huo Ji; Jian-Jun Yang; Chen-Zhuo Feng
Journal:  Front Mol Neurosci       Date:  2015-09-23       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.